1859
A biotechnology company focused on the discovery and development of next-generation therapeutics.
3
Funding Rounds
$87.7m
Money raised
Funding
Funding series
Funding Series Analysis
The company 1859 has raised a total of $80m in funding over 3 rounds.
Key Insights:
- 1859 (company) Series A round, February 7, 2022: $40m
- 1859 Funding Round, November 2021: $40m
- 1859, Inc. funding round, August 2020: $7.71m
1859 (company) Series A round, February 7, 2022
$40m
1859 Funding Round, November 2021
$40m
1859, Inc. funding round, August 2020
$7.71m
Industries
1859 is active in the following industries: